Cargando…

Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Background: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer is of great signi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IEEE 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932521/
https://www.ncbi.nlm.nih.gov/pubmed/35317416
http://dx.doi.org/10.1109/JTEHM.2022.3156851
_version_ 1784671457808220160
collection PubMed
description Background: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer is of great significance for the subsequent treatment of patients. Methods: In this study, we propose a new pathological images analysis method based on multi-instance learning to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Specifically, we proposed a gated attention normalization mechanism based on the multilayer perceptron, which accelerates the convergence of stochastic gradient descent optimization and can speed up the training process. We also proposed a bilinear attention multi-scale feature fusion mechanism, which organically fuses the global features of the larger receptive fields and the detailed features of the smaller receptive fields and alleviates the problem of pathological images context information loss caused by block sampling. At the same time, we also designed a weighted loss function to alleviate the problem of imbalance between cancerous instances and normal instances. Results: We evaluated our method on a locally advanced rectal cancer dataset containing 150 whole slide images. In addition, to verify our method’s generalization performance, we also tested on two publicly available datasets, Camelyon16 and MSKCC. The results show that the AUC values of our method on the Camelyon16 and MSKCC datasets reach 0.9337 and 0.9091, respectively. Conclusion: Our method has outstanding performance and advantages in predicting the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Clinical and Translational Impact Statement—This study aims to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer to assist clinicians quickly diagnose and formulate personalized treatment plans for patients.
format Online
Article
Text
id pubmed-8932521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher IEEE
record_format MEDLINE/PubMed
spelling pubmed-89325212022-03-21 Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer IEEE J Transl Eng Health Med Article Background: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer is of great significance for the subsequent treatment of patients. Methods: In this study, we propose a new pathological images analysis method based on multi-instance learning to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Specifically, we proposed a gated attention normalization mechanism based on the multilayer perceptron, which accelerates the convergence of stochastic gradient descent optimization and can speed up the training process. We also proposed a bilinear attention multi-scale feature fusion mechanism, which organically fuses the global features of the larger receptive fields and the detailed features of the smaller receptive fields and alleviates the problem of pathological images context information loss caused by block sampling. At the same time, we also designed a weighted loss function to alleviate the problem of imbalance between cancerous instances and normal instances. Results: We evaluated our method on a locally advanced rectal cancer dataset containing 150 whole slide images. In addition, to verify our method’s generalization performance, we also tested on two publicly available datasets, Camelyon16 and MSKCC. The results show that the AUC values of our method on the Camelyon16 and MSKCC datasets reach 0.9337 and 0.9091, respectively. Conclusion: Our method has outstanding performance and advantages in predicting the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Clinical and Translational Impact Statement—This study aims to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer to assist clinicians quickly diagnose and formulate personalized treatment plans for patients. IEEE 2022-03-03 /pmc/articles/PMC8932521/ /pubmed/35317416 http://dx.doi.org/10.1109/JTEHM.2022.3156851 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. For more information, see https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Article
Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title_full Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title_fullStr Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title_full_unstemmed Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title_short Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer
title_sort using multi-scale convolutional neural network based on multi-instance learning to predict the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932521/
https://www.ncbi.nlm.nih.gov/pubmed/35317416
http://dx.doi.org/10.1109/JTEHM.2022.3156851
work_keys_str_mv AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer
AT usingmultiscaleconvolutionalneuralnetworkbasedonmultiinstancelearningtopredicttheefficacyofneoadjuvantchemoradiotherapyforrectalcancer